Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Anbogen Raises $12.5 Million to Develop Precision Oncology Portfolio

publication date: Feb 5, 2024

Anbogen Therapeutics, a Taipei clinical-stage prevision oncology company, raised $12.5 million in a Series A funding round. to advance its two lead drug candidates, ABT-101 and ABT-301. Both candidates were supported by Taiwan’s National Research Program for Biopharmaceuticals (NRPB) before they were acquired by Anbogen. ABT-101 is a HER2-targeting tyrosine kinase inhibitor, and ABT-301 is a novel small molecule drug that potentiates efficacy of immune checkpoint inhibitors. Anbogen’s A round was led by China Development Industrial Bank with participating from Taian Venture Capital, Maxpro and the National Development Fund. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here